Aim: We aimed to compare the results of photorefractive keratectomy (PRK) and femtosecond-assisted laser in situ keratomileusis (FS-LASIK) procedures in the treatment of myopia and myopic astigmatism.
Material and Method: Seventy eyes of 35 patients with myopia and/or myopic astigmatism who had undergone PRK procedure were compared retrospectively with 70 eyes of 35 patients with myopia and/or myopic astigmatism who had undergone FS-LASIK procedure.
Results: All patients completed the 2-year follow-up period. With respect to age and sex, PRK and FS-LASIK groups were comparable. The differences in uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and spherical equivalent were significantly better with PRK than with FS-LASIK at 6- and 24-month visits. FS-LASIK and PRK had similar values of safety index, efficacy index, and predictability at 6 and 24 months postoperatively. No significant complications were observed in neither of the procedures during the follow-up period.
Conclusion: Both PRK and FS-LASIK seem equally effective options for the correction of myopia and myopic astigmatism. However, PRK provided slightly better visual and refractive outcomes than FS-LASIK at 6 and 24 months postoperatively.
Laser in situ keratomileusis Myopia Myopic astigmatism Photorefractive keratectomy Refractive surgery
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Original Article |
Authors | |
Publication Date | January 17, 2022 |
Published in Issue | Year 2022 Volume: 5 Issue: 1 |
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.